首页 | 本学科首页   官方微博 | 高级检索  
   检索      

微小RNA与肺癌耐药
引用本文:董琢,杨丽华,钟智伟,龚朝辉.微小RNA与肺癌耐药[J].细胞生物学杂志,2012(4):391-397.
作者姓名:董琢  杨丽华  钟智伟  龚朝辉
作者单位:宁波大学医学院,宁波315211
基金项目:浙江省教育厅重点项目(No.Z201119414)、宁波市科技创新团队项目(No.2011882014)宁宁波大学王宽诚教育基金资助项目
摘    要:肺癌细胞对化疗药物产生耐药性是目前肺癌化疗过程中遇到的主要问题。微小RNA(miRNA)是一类内源性非编码短链小分子RNA,它能调节细胞生长、凋亡和信号转导。miRNA的多态性与药物代谢和耐药形成密切相关,异常表达的miRNA对预测肺癌化疗药物敏感性有重要作用。调节特异miRNA的表达,将为克服肺癌耐药和选择个体化治疗开辟新的途径。

关 键 词:微小RNA  多态性  肺癌  化疗耐药  个体化治疗

MicroRNA and Drug Resistance in Lung Cancer
Dong Zhuo,Yang Lihua,Zhong Zhiwei,Gong Zhaohui.MicroRNA and Drug Resistance in Lung Cancer[J].Chinese Journal of Cell Biology,2012(4):391-397.
Authors:Dong Zhuo  Yang Lihua  Zhong Zhiwei  Gong Zhaohui
Institution:(School of Medicine, Ningbo University, Ningbo 315211, China)
Abstract:Drug resistance induced by chemotherapeutants to lung cancer cells is the primary issue aurlng the chemotherapy of lung cancer. MicroRNAs (miRNAs) are a class of endogenetic, non-coding, short-chain and small RNAs that regulate cell growth, apoptosis and signaling transduction, miRNA polymorphisms associte with drug metabolsim and drug resistance formation. Moreover, differentially expressed miRNAs play critical roles in prediction of the sensitivity to chemotherapeutic agents in lung cancer. Regulation of specific miRNA expression will break a new path for overcoming lung cancer resistance and the personalized therapy.
Keywords:microRNA  polymorphism  lung cancer  chemoresistance  personalized therapy
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号